Upgrades
For The Toro Co (NYSE:TTC), Raymond James upgraded the previous rating of Market Perform to Outperform. For the fourth quarter, Toro had an EPS of $1.11, compared to year-ago quarter EPS of $0.56. The current stock performance of Toro shows a 52-week-high of $115.57 and a 52-week-low of $71.86. Moreover, at the end of the last trading period, the closing price was at $111.15.
See all analyst ratings upgrades.
Downgrades
For Paramount Global (NASDAQ:PARA), Loop Capital downgraded the previous rating of Hold to Sell. For the third quarter, Paramount Global had an EPS of $0.39, compared to year-ago quarter EPS of $0.76. At the moment, the stock has a 52-week-high of $39.21 and a 52-week-low of $15.29. Paramount Global closed at $16.94 at the end of the last trading period.
JMP Securities downgraded the previous rating for Applied Molecular Transport Inc (NASDAQ:AMTI) from Market Outperform to Market Perform. For the third quarter, Applied Molecular had an EPS of $0.65, compared to year-ago quarter EPS of $0.68. The stock has a 52-week-high of $14.94 and a 52-week-low of $0.80. At the end of the last trading period, Applied Molecular closed at $1.03.
See all analyst ratings downgrades.
Initiations
With an Overweight rating, Cantor Fitzgerald initiated coverage on Array Technologies Inc (NASDAQ:ARRY). The price target seems to have been set at $26.00 for Array Technologies. Array Technologies earned $0.18 in the third quarter, compared to $0.07 in the year-ago quarter. The current stock performance of Array Technologies shows a 52-week-high of $24.24 and a 52-week-low of $5.45. Moreover, at the end of the last trading period, the closing price was at $20.99.
Benchmark initiated coverage on Nutex Health Inc (NASDAQ:NUTX) with a Buy rating. The price target for Nutex Health is set to $3.00. For the third quarter, Nutex Health had an EPS of $0.65, compared to year-ago quarter EPS of $0.09. The current stock performance of Nutex Health shows a 52-week-high of $52.80 and a 52-week-low of $0.50. Moreover, at the end of the last trading period, the closing price was at $2.12.
Daiwa Capital initiated coverage on First Solar Inc (NASDAQ:FSLR) with an Outperform rating. The price target for First Solar is set to $175.00. In the third quarter, First Solar showed an EPS of $0.46, compared to $0.42 from the year-ago quarter. The stock has a 52-week-high of $173.68 and a 52-week-low of $59.60. At the end of the last trading period, First Solar closed at $156.89.
With a Neutral rating, Daiwa Capital initiated coverage on SolarEdge Technologies Inc (NASDAQ:SEDG). The price target seems to have been set at $325.00 for SolarEdge Technologies. For the third quarter, SolarEdge Technologies had an EPS of $0.91, compared to year-ago quarter EPS of $1.45. At the moment, the stock has a 52-week-high of $375.90 and a 52-week-low of $190.15. SolarEdge Technologies closed at $311.46 at the end of the last trading period.
Credit Suisse initiated coverage on Marsh & McLennan Companies Inc (NYSE:MMC) with a Neutral rating. The price target for Marsh & McLennan is set to $157.00. For the third quarter, Marsh & McLennan had an EPS of $1.18, compared to year-ago quarter EPS of $1.08. The current stock performance of Marsh & McLennan shows a 52-week-high of $183.14 and a 52-week-low of $142.80. Moreover, at the end of the last trading period, the closing price was at $165.70.
Daiwa Capital initiated coverage on Enphase Energy Inc (NASDAQ:ENPH) with an Outperform rating. The price target for Enphase Energy is set to $335.00. Enphase Energy earned $1.25 in the third quarter, compared to $0.60 in the year-ago quarter. At the moment, the stock has a 52-week-high of $339.92 and a 52-week-low of $113.40. Enphase Energy closed at $298.87 at the end of the last trading period.
Chardan Capital initiated coverage on Anixa Biosciences Inc (NASDAQ:ANIX) with a Buy rating. The price target for Anixa Biosciences is set to $8.00. Anixa Biosciences earned $0.09 in the third quarter, compared to $0.14 in the year-ago quarter. The current stock performance of Anixa Biosciences shows a 52-week-high of $6.25 and a 52-week-low of $2.30. Moreover, at the end of the last trading period, the closing price was at $3.81.
See all analyst ratings initiations.
